MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Prodigiosin

CAS No. : 82-89-3

MCE 国际站：Prodigiosin

产品活性：Prodigiosin (Prodigiosine)，一种天然的红色素，是一种具有生物活性的次生代谢产物。Prodigiosin 是 Wnt/β-catenin 途径的有效抑制剂。Prodigiosin 具有抗菌，抗真菌，抗原生动物，抗疟疾，免疫抑制和抗癌特性。

研究领域：Apoptosis | Stem Cell/Wnt | Anti-infection

作用靶点：Bacterial | Apoptosis | Wnt | Fungal | Parasite

In Vitro: Prodigiosin (25-500 nM; 24 hours) treatment reduces the viability of breast cancer cells, with IC₅₀ values at 48 h of 62.52 nM in MDA-MB-231 cells and 261.2 nM in MDA-MB-468 cells.
Prodigiosin (25-500 nM; 24 hours) treatment significantly reduces the levels of phosphorylated LRP6 and DVL2, active β-catenin, and total β-catenin. Prodigiosin noticeably inhibits the phosphorylation of GSK3β at Ser9 in HEK293T cells, which is indicative of an increase in GSK3β activity.
Prodigiosin can inhibit proliferation and induce apoptosis in breast cancer cells.
Prodigiosin (25-500 nM; 24 hours) treatment dose-dependently blocks Wnt signaling activated by Wnt1, Wnt3, Wnt1/LRP6, Wnt3/LRP6, and Dishevelled 2 (DVL2) in transfected HEK293T cells. Prodigiosin treatment inhibits Wnt3A-CM-induced transcription in a dose-dependent manner. Prodigiosin inhibits transcription of the SuperTopFlash reporter activated by either Wnt transfection or Wnt3A treatment.
When applied to cultures of chytrid fungi Batrachochytrium dendrobatidis and B. salamandrivorans, Prodigiosin causes significant growth inhibition, with MIC values of 10 µM and 50 µM, respectively.

In Vivo: Prodigiosin (5 mg/kg; intraperitoneal injection; twice weekly; for 3 weeks) treatment significantly inhibits tumor growth. Prodigiosin treatment decreases tumor cell density and expression of the proliferation marker Ki-67.

相关产品：MG-132 | Rapamycin | Ferrostatin-1 | LY294002 | Doxorubicin hydrochloride | Bafilomycin A1 | Chloroquine | Y-27632 dihydrochloride | Puromycin dihydrochloride | Paclitaxel | Cycloheximide | Laduviglusib | Angiotensin II human | Acetylcysteine | Dexamethasone | Staurosporine | Tamoxifen | 5-Fluorouracil | Bortezomib | Sorafenib | 2-Deoxy-D-glucose | Trametinib | SP600125 | Gemcitabine | Temozolomide | G-418 disulfate | Doxycycline (hyclate) | MK-2206 dihydrochloride | Verteporfin

热门产品线：重组蛋白 | 化合物库 | 天然产物 | 染料试剂 | PROTAC | 同位素标记物

Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。